Super-aging Japan faces a dual challenge: rising non-communicable disease (NCD) burden and persistent vulnerability to vaccine-preventable respiratory infections. With nearly 75% of deaths linked to NCDs and growing evidence that infections like influenza and pneumonia accelerate chronic disease progression, adult immunization must be viewed not only as infectious disease prevention, but as a core healthy…

Released in January 2026, these Calls to Action capture insights and outcomes from a GCOA-convened expert working group session in 2025 to advance implementation of integrated adult immunization and chronic disease strategies in the European Union. Building on insights from GCOA’s April 2025 report and consensus statement Vaccine-Preventable Respiratory Disease, Life Course Immunization, and Chronic…

As America ages, Medicare must evolve to meet the needs of a growing population living longer with complex health conditions. Aortic stenosis — a serious, age-related heart disease — can be fatal if left untreated, yet current Medicare policy limits access to the life-saving, minimally invasive procedure known as TAVR (Transcatheter Aortic Valve Replacement) until…

Grounded in insights from a series of GCOA-led expert roundtables, developed in partnership with Lilly, the Playbook captures lessons learned from experts and leaders across major disease areas — including cancer, HIV/AIDS, cardiovascular disease, and diabetes — to identify proven strategies that can accelerate progress in Alzheimer’s. By bridging insights from other successful health movements,…

The central narrative lays out three pillars that are essential to the new prevention paradigm for the 21st century, centered around adult immunization: Innovative Medicines, Vaccines and Models: Scaling Breakthroughs to Unlock Prevention Resilient Health Systems: Creating Readiness for a Super-Aging Society Smart Aging Investments: Maximizing the Full Value of Longevity for Workforces and Communities